EC Number   |
Application |
Reference  |
|---|
   3.4.24.75 | medicine |
therapeutic agent for the treatment of Staphylococcus aureus infections |
667220 |
| 3.4.24.75 | medicine |
staphylococcal disease pathogenesis |
668814 |
| 3.4.24.75 | medicine |
treatment of staphylococcal infections |
669118 |
| 3.4.24.75 | medicine |
application as effective antibiotic drug against infections with Staphylococcus aureus |
670123 |
| 3.4.24.75 | medicine |
lysostaphin is useful in treatment of neonatal Staphylococcus aureus infection, overview |
683082 |
| 3.4.24.75 | pharmacology |
lysostaphin is useful for treatment for systemic Staphylococcus aureus infection in a mouse model |
683596 |
| 3.4.24.75 | analysis |
improvement of lipid extraction of staphylococcal cells |
695804 |
| 3.4.24.75 | diagnostics |
detection of Staphylococcus aureus |
695804 |
| 3.4.24.75 | food industry |
antistaphylococcal agent |
695804 |
| 3.4.24.75 | medicine |
potential therapeutic agent against antibiotic-resistant Staphylococcus aureus infections |
695804 |
